Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis. (2015)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.39169

PubMed Identifier: 26109489

Publication URI: http://europepmc.org/abstract/MED/26109489

Type: Journal Article/Review

Volume: 67

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 8

ISSN: 2326-5191